Literature DB >> 717430

Comparison of dewpoint and freezing point osmometry.

D E Mercier, R D Feld, D L Witte.   

Abstract

Osmolality was measured on 32 clear serum samples and on 23 urines, with dewpoint and with freezing point osmometers. The observed regression equation was dewpoint = 0.96 freezing point +7.6, with a correlation mean for 32 clear sera analyzed by both methods was not significantly different. However, when 14 lipemic sera were analyzed, the dewpoint measurements were higher: X dewpoint = 291.6; X freezing point = 284.1. The between-run standard deviation observed for a normal serum pool yielded a coefficient of variation of 1.04 with the freezing point and 2.38 with the dewpoint instrument. Results indicate that the dewpoint device should be used with caution for lipemic serum samples.

Mesh:

Substances:

Year:  1978        PMID: 717430

Source DB:  PubMed          Journal:  Am J Med Technol        ISSN: 0002-9335


  5 in total

1.  Osmosis, osmometry, and osmoregulation.

Authors:  R C Lord
Journal:  Postgrad Med J       Date:  1999-02       Impact factor: 2.401

2.  Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.

Authors:  T Baba; S Murabayashi; K Aoyagi; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.

Authors:  T Baba; S Murabayashi; T Tomiyama; K Takebe
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.

Authors:  T Baba; S Murabayashi; K Takebe
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

5.  Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy.

Authors:  T Baba; T Tomiyama; S Murabayashi; K Takebe
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.